# Comparison of Efficacy of Double Dose Oral Terbinafine Vs Itraconazole in Treatment of Dermatophyte Infections of Skin.

> **NCT04880980** · PHASE3 · COMPLETED · sponsor: **Pak Emirates Military Hospital** · enrollment: 120 (actual)

## Conditions studied

- Dermatophyte Infection
- Terbinafine Adverse Reaction
- Itraconazole Adverse Reaction

## Interventions

- **DRUG:** Terbinafine Pill
- **DRUG:** Itraconazole capsule

## Key facts

- **NCT ID:** NCT04880980
- **Lead sponsor:** Pak Emirates Military Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-15
- **Primary completion:** 2022-03-15
- **Final completion:** 2022-03-15
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2022-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04880980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04880980, "Comparison of Efficacy of Double Dose Oral Terbinafine Vs Itraconazole in Treatment of Dermatophyte Infections of Skin.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04880980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*